Cannabis Law Report

JULY 8, 2021

(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

LifeCannMD

AUGUST 2, 2024

Cannabinoids have been shown to have anti-inflammatory effects, which may help reduce the inflammation that can contribute to migraines.Cannabis influences neurotransmitter release, helping to modulate the neural pathways involved in migraine development. More clinical trials are needed to establish definitive efficacy and safety profiles.

Clinical Trials 52

Clinical Trials Marijuana Research and Development Cannabinoids 52

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. Junk’ cannabis ‘ill-suited for clinical trials’.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

JUNE 19, 2022

The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Initial goals of the center are focused on research and educational initiatives.

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”).

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We This product candidate is being funded through a Cooperative Research and Development Agreement (CRADA) with the National Center for Advancing Translational Sciences (NCATS).

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS IND-enabling studies for Envelta are being performed under a Cooperative Research and Development Agreement (CRADA) with NCATS entered into by Virpax in August of 2020. “We

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

MMJ Recs

AUGUST 14, 2024

This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research. We’ll talk a bit more about this topic below. How Does Medical Marijuana Help Neuropathic Pain? Follow up on your response and adjust the dosage as needed.

Nerve Pain 96

Nerve Pain Marijuana Strains Chronic Pain 96

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Furthermore, pharmaceutical companies often fund and initiate randomised clinical trials to validate their drugs.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. RYAH’s database provides that type of scale to all parties involved – patients, doctors, researchers, drug developers, growers, etc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. It covers the pipeline drug profiles, including clinical and nonclinical stage products. GWP42003-P: GW Research. Epilepsy Emerging Drugs Chapters.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 10, 2019

They write, “ At the Center for Psychedelic and Consciousness Research, researchers will focus on how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. The researchers hope to create precision medicine treatments tailored to the specific needs of individual patients.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

Cannabis Law Report

SEPTEMBER 20, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, has acquired the exclusive worldwide rights from Nanomerics Ltd. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

JUNE 15, 2022

Materia is one of many other operators that have recently established a headquarters in Malta since the legislation permitting the production of medical cannabis products for research and medical purposes was enacted in 2018. Malta is an ideal testbed for research given its small size and business-friendly approach.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Packaging 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

AUGUST 17, 2021

This growth opportunity-technology report explores innovations and patents in this space and provides more details about notable companies that are making strides in research and development. Key Topics Covered: 1.0 Research Context and Key Findings. Research Scope. Research Methodology. Research Scope.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

MMJ Recs

MAY 9, 2024

Exploring Different Consumption Methods: Medical marijuana comes in various forms, including flowers, concentrates, edibles, tinctures, and topicals. Veterans’ Access to Medical Marijuana The benefits of medical cannabis for veterans are many, but access to medical marijuana for veterans has been a topic of ongoing debate and advocacy.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

JANUARY 19, 2022

During his 24 years in Congress, Congressman Moran was recognized as a champion of innovative research and development in areas including healthcare and national security, environmental protection and sustainability, and international trade and fiscal responsibility. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

Cannabis Law Report

MARCH 16, 2022

PsyBio Therapeutics to Make Significant Environmental, Social, and Governance (ESG) Commitment to Promote Mental and Neurological Health While Working to Develop State of the Art Technologies, Process Skills and Capabilities in Lesotho and Across Africa. OXFORD, Ohio and COCONUT CREEK, Fla., per SVS.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Medicine 52

PrestoDoctor

OCTOBER 11, 2023

For years, the use of cannabis has been a controversial topic. One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Some individuals may have delayed speech development or struggle with expressing their thoughts and emotions effectively.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Cannabis Law Report

AUGUST 16, 2021

–(BUSINESS WIRE)–Celebrity blogger and media personality Perez Hilton and leading hemp-based CBD researchers have forged a business partnership in support of My True 10 , a CBD Gummies line available at mytrue10.com Perez Hilton’s Personal Wellness Journey Encourages & Supports Others to Live Well. CARSON CITY, Nev.–(BUSINESS

Food 105

Food CBD Research and Development Clinical Trials 105

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1: Bionorica SE BX-1 is an oral solution containing dronabinol, being developed by Bionorica. Dronabinol is a synthetic form of ??-THC,

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

OCTOBER 1, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, today announced that Chairman and CEO Anthony P. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

The Cannigma

SEPTEMBER 21, 2021

Patrick Stewart uses topicals and edibles for his arthritis (Shutterstock). Chong told Forbes that after he was cast on Dancing With The Stars, the stress and strain of the dancing built up and led him, in his estimation, to develop rectal cancer as well. 1) Patrick Stewart. 7) Morgan Freeman. 8) Michael J. The Michael J.

Patients 96

Patients Research and Development Sleep Clinical Trials 96

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 123

History Microdosing Research and Development Clinical Trials 123

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1 is an oral solution containing dronabinol, being developed by Bionorica. THX-110 is a being developed by Therapix Biosciences.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

United Patients Group

JANUARY 5, 2023

Probiotics are a hot topic these days, and for good reason. A growing body of research suggests that probiotics can help protect us from illness and disease, improve our mental health, and strengthen our immune system. Probiotics may reduce the risk of developing a cold or flu. Introduction. Probiotics May Reduce Flu Risk.

Digestion 105

Digestion Research and Development Food Strains 105

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Marijuana law reform advocates and many medical researchers have been fighting to change marijuana’s Schedule I classification for years. Schedule I classification typically pertains to narcotic substances with no medical value.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

JUNE 25, 2021

This acquisition would also help Bristol-Myers Squibb to expedite the development of new innovative drugs which are in the early stages of drug pipeline. Celgene is an innovative biotechnology company that manufactures and develops cancer drugs. Key Topics Covered: 1. Cancer Research Centers. Executive Summary.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease. Cost of revenue. . .

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

The Cannigma

JUNE 24, 2021

Research has found that meditation can potentially have a variety of health benefits , including lowering blood pressure, reducing anxiety and depression, and may even provide some relief from conditions like irritable bowel syndrome and ulcerative colitis. Meditation and mindfulness. How CBD and cannabis products can help.

CBD 78

CBD Microdosing Edibles Sleep 78

Cannabis Law Report

FEBRUARY 25, 2019

The development of an accurate and reliable delivery vector is a critical step for cannabis components to be accepted by the wider community as “medicine”. Syqe Medical was founded in 2011 in order to develop a measurable and repeatable method of administering medical cannabis. It’s very instinctive.

THC 40

THC CBD Research and Development Clinical Trials 40

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Today’s guest is Itai Rogel, the Vice President of Business Development at Israeli cannabis company, Bazelet. Music by Desca.

Research and Development 83

Research and Development Oil Cannabis Clinical Trials 83